Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity

Cited by (1,003)

Items 101–200 of 1,003

1. Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
   Laura Kate Gadanec, Kristen Renee McSweeney, Tawar Qaradakhi, Benazir Ashiana Ali, Anthony Zulli, Vasso Apostolopoulos · 2021 · International Journal of Molecular Sciences
2. The Polybasic Cleavage Site in SARS-CoV-2 Spike Modulates Viral Sensitivity to Type I Interferon and IFITM2
   Helena Winstone, María José Lista, Alisha C. Reid, Clément R. Bouton, Suzanne Pickering, Rui Pedro Galão, Claire Kerridge, Katie J. Doores, Chad M. Swanson, Stuart J. D. Neil · 2021 · Journal of Virology
3. Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2
   Tanushree Dangi, Jacob Class, Nicole M. Palacio, Justin M. Richner, Pablo Penaloza‐MacMaster · 2021 · Cell Reports
4. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity
   Otávio Cabral-Marques, Gilad Halpert, Lena F. Schimke, Yuri Ostrinski, Aristo Vojdani, Gabriela Crispim Baiocchi, Paula Paccielli Freire, Igor Salerno Filgueiras, Israel Zyskind, Miriam Temmeh Lattin et al. · 2022 · Nature Communications
5. Systematic analysis of SARS-CoV-2 infection of an ACE2-negative human airway cell
   Maritza Puray‐Chavez, Kyle M. LaPak, Travis Parke Schrank, Jennifer L. Elliott, Dhaval P. Bhatt, Megan J. Agajanian, Ria Jasuja, Dana Q. Lawson, Keanu Davis, Paul W. Rothlauf et al. · 2021 · Cell Reports
6. Rapid endotheliitis and vascular damage characterize SARS-CoV-2 infection in a human lung-on-chip model
   Thacker, Vivek V, Sharma, Kunal, Dhar, Neeraj, Mancini, Gian-Filippo, Sordet-Dessimoz, Jessica, McKinney, John D · 2021 · The EMBO Reports
7. Furin cleavage of the SARS-CoV-2 spike is modulated by O -glycosylation
   Liping Zhang, Matthew D. Mann, Zulfeqhar Ali Syed, Hayley M. Reynolds, E Tian, Nadine L. Samara, Darryl C. Zeldin, Lawrence A. Tabak, Kelly G. Ten Hagen · 2021 · Proceedings of the National Academy of Sciences
8. Exosome-mediated mRNA delivery in vivo is safe and can be used to induce SARS-CoV-2 immunity
   Tsai, Shang Jui, Atai, Nadia A., Cacciottolo, Mafalda, Nice, Justin, Salehi, Arjang, Guo, Chenxu, Sedgwick, Alanna, Kanagavelu, Saravana, Gould, Stephen J. · 2021 · Journal of Biological Chemistry
9. European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology, pathophysiology, and diagnosis
   The Task Force for the management of COVID-19 of the European Society of Cardiology, Colin Baigent, Stephan Windecker, Daniele Andreini, Elena Arbelo, Emanuele Barbato, Antonio Luca Bartorelli, Andreas Baumbach, Elijah Raphael Behr, Sérgio Luis Berti et al. · 2021 · European Heart Journal
10. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy
    Yi-Zhou Jiang, Limor Rubin, Tangming Peng, Linlin Liu, Xingan Xing, Philip Lazarovici, Wenhua Zheng · 2021 · International Journal of Biological Sciences
11. SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro
    Feng-Ming Liu, Kun Han, R. Blair, Kornelia Kenst, Zhong-Hua Qin, Berin Upcin, Philipp Wörsdörfer, C. Midkiff, Joseph C. Mudd, E. Belyaeva et al. · 2021 · Frontiers in Cellular and Infection Microbiology
12. Role of Hypertension on the Severity of COVID-19: A Review
    Mei Peng, Jia He, Ying Xue, Yang Xue, Shao Liu, Zhicheng Gong · 2021 · Journal of Cardiovascular Pharmacology
13. Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy
    Ying Wang, Chen Yang, Yutong Song, John Robert Coleman, Marcin Stawowczyk, Juliana Tafrova, Sybil A. Tasker, David A. Boltz, Robert Baker, Liliana Garcia et al. · 2021 · Proceedings of the National Academy of Sciences
14. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2
    McCallum, Matthew, Marco, Anna De, Lempp, Florian, Tortorici, M. Alejandra, Pinto, Dora, Walls, Alexandra C., Beltramello, Martina, Chen, Alex, Liu, Zhuoming, Zatta, Fabrizia et al. · 2021
15. Neurological complications and infection mechanism of SARS-CoV-2
    Dandan Wan, Tingfu Du, Weiqi Hong, Li Chen, Haiying Que, Shuaiyao Lu, Xiaozhong Peng · 2021 · Signal Transduction and Targeted Therapy
16. Endothelial cells are not productively infected by SARS‐CoV‐2
    Lilian Schimmel, Keng Yih Chew, Claudia J. Stocks, Teodor E. Yordanov, Patricia Essebier, Arutha Kulasinghe, James H. Monkman, Anna Flavia Ribeiro dos Santos Miggiolaro, Caroline Louise Cooper, Lúcia de Noronha et al. · 2021 · Clinical & Translational Immunology
17. Comparison of Four SARS-CoV-2 Neutralization Assays
    Riepler, Lydia, Rössler, Annika, Falch, Albert, Volland, André, Borena, Wegene, von Laer, Dorothee, Kimpel, Janine · 2020 · Vaccines
18. Neutralizing antibodies for the prevention and treatment of COVID-19
    Lanying Du, Yang Yang, Xiujuan Zhang · 2021 · Cellular and Molecular Immunology
19. Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies
    Darrell O. Ricke · 2021 · Frontiers in Immunology
20. Molecular diversity of coronavirus host cell entry receptors
    Jean K. Millet, Javier A. Jaimes, Gary R. Whittaker · 2020 · FEMS Microbiology Reviews
21. ACE2: the molecular doorway to SARS-CoV-2
    Miriam Marlene Medina-Enríquez, Sandra López‐León, José Alberto Carlos-Escalante, Zuleika Aponte Torres, Angélica Cuapio, Talía Wegman-Ostrosky · 2020 · Cell & Bioscience
22. Phosphatidylserine receptors enhance SARS-CoV-2 infection
    Dana Bohan, Hanora A. Van Ert, Natalie Ruggio, Kai J. Rogers, Mohammad Badreddine, José A. Aguilar-Briseño, Jonah M. Elliff, Roberth Anthony Rojas Chávez, Boning Gao, Tomasz Stokowy et al. · 2021 · PLoS Pathogens
23. Endocytosis of abiotic nanomaterials and nanobiovectors: Inhibition of membrane trafficking
    Pooyan Makvandi, Meiling Chen, Rossella Sartorius, Ali Zarrabi, Milad Ashrafizadeh, Farnaz Dabbagh Moghaddam, Jingzhi Ma, Virgilio Mattoli, Franklin R. Tay · 2021 · Nano Today
24. Infectious agents and Alzheimer's disease
    Piekut, Thomas, Hurła, Mikołaj, Banaszek, Natalia, Szejn, Paulina, Dorszewska, Jolanta, Kozubski, Wojciech, Prendecki, Michał · 2022 · Journal of Integrative Neuroscience
25. Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2
    Jéromine Klingler, Svenja Weiß, Vincenza Itri, Xiaomei Liu, Kasopefoluwa Y. Oguntuyo, Christian S. Stevens, Satoshi Ikegame, Chuan-Tien Hung, Gospel M Enyindah-Asonye, Fatima Amanat et al. · 2020 · The Journal of Infectious Diseases
26. New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic
    Heli Salmi, Santtu Heinonen, Johanna Hästbacka, Mitja Lääperi, Paula Rautiainen, Päivi Johanna Miettinen, Olli P. Vapalahti, Jussi Hepojoki, Mikael Knip · 2021 · Archives of Disease in Childhood
27. SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes
    Yijia Li, Alexis M. Schneider, Arnav Mehta, Moshe Sade-Feldman, Kyle R. Kays, Matteo Gentili, Nicole C. Charland, Anna L. K. Gonye, Irena Gushterova, Hargun K. Khanna et al. · 2021 · Journal of Clinical Investigation
28. Structure genomics of SARS-CoV-2 and its Omicron variant: drug design templates for COVID-19
    Canrong Wu, Wanchao Yin, Yi Jiang, H. Eric Xu · 2022 · Acta Pharmacologica Sinica
29. Neuropilin-1 Mediates SARS-CoV-2 Infection of Astrocytes in Brain Organoids, Inducing Inflammation Leading to Dysfunction and Death of Neurons
    Weili Kong, Mauricio Montaño, Michael J. Corley, Ekram W. Helmy, Hirofumi Kobayashi, Martin Kinisu, Rahul K. Suryawanshi, Xiaoyu Luo, Löıc A. Royer, Nadia R. Roan et al. · 2022 · mBio
30. SARS-CoV-2 infection triggers pro-atherogenic inflammatory responses in human coronary vessels
    Natalia Eberhardt, Maria Gabriela Noval, Ravneet Kaur, Letizia Amadori, Michael A. Gildea, Swathy Sajja, Dayasagar Das, Burak Cılhoroz, O’Jay Stewart, Dawn M. Fernandez et al. · 2023 · Nature Cardiovascular Research
31. SARS-CoV-2 Infection of Microglia Elicits Proinflammatory Activation and Apoptotic Cell Death
    Gi Uk Jeong, Jaemyun Lyu, Kyun‐Do Kim, Young Cheul Chung, Gun Young Yoon, Sumin Lee, Insu Hwang, Won-Ho Shin, Junsu Ko, June‐Yong Lee et al. · 2022 · Microbiology Spectrum
32. COVID-19 and cognitive impairment: neuroinvasive and blood‒brain barrier dysfunction
    Yan‐Ting Chen, Wenren Yang, Feng Chen, Lili Cui · 2022 · Journal of Neuroinflammation
33. Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain
    Amelia J. McFarland, Muhammad Saad Yousuf, Stephanie I. Shiers, Theodore John Price · 2021 · PAIN Reports
34. SARS-CoV-2 Invades the Central Nervous System via the Olfactory Route in Rhesus Monkeys
    Jiao Li, Yun Yang, Wenhai Yu, Yuan Zhao, Haiting Long, Jiahong Gao, Kaiyun Ding, Chunxia Ma, Jingmei Li, Siwen Zhao et al. · 2020 · Signal Transduction and Targeted Therapy
35. Cholesterol-Rich Lipid Rafts as Platforms for SARS-CoV-2 Entry
    Selvin Noé Palacios-Rápalo, Luis Adrián De Jesús‐González, Carlos Daniel Cordero‐Rivera, Carlos Noe Farfán-Morales, Juan Fidel Osuna‐Ramos, Gustavo Martínez-Mier, Judith Quistián-Galván, Armando Muñoz-Pérez, Víctor Bernal-Dolores, Rosa María del Ángel et al. · 2021 · Frontiers in Immunology
36. Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review
    Fien Demeulemeester, Karin de Punder, Marloes van Heijningen, Femke van Doesburg · 2021 · Cells
37. The olfactory nerve is not a likely route to brain infection in COVID-19: a critical review of data from humans and animal models
    Rafał Butowt, Nicolas Meunier, Bertrand Bryche, Christopher S. von Bartheld · 2021 · Acta Neuropathologica
38. SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages
    Giovanny J. Martínez-Colón, Kalani Ratnasiri, Richard Chen, Sizun Jiang, ELIZABETH J. ZANLEY, Arjun Rustagi, Renu Verma, Han M. Chen, Jason Randolph Andrews, Kirsten D. Mertz et al. · 2022 · Science Translational Medicine
39. SARS-CoV-2 spike engagement of ACE2 primes S2′ site cleavage and fusion initiation
    Shi Yu, Xu Zheng, Bingjie Zhou, Juan Li, Mengdan Chen, Rong Xin Deng, Gary Wong, Dimitri Lavillette, Guangxun Meng · 2021 · Proceedings of the National Academy of Sciences
40. Dissecting lipid metabolism alterations in SARS-CoV-2
    Ilaria Casari, Marcello Manfredi, Pat Metharom, Marco Falasca · 2021 · Progress in Lipid Research
41. Vasculopathy in COVID-19
    Robert C. Flaumenhaft, Keiichi Enjyoji, Alec A. Schmaier · 2022 · Blood
42. Inflammatory responses in the placenta upon SARS-CoV-2 infection late in pregnancy
    Lissenya B. Argueta, Lauretta A. Lacko, Yaron Bram, Takuya Tada, Lucía Carrau, André F. Rendeiro, Tuo Zhang, Skyler A. Uhl, Brienne Lubor, Vasuretha Chandar et al. · 2022 · iScience
43. Extracellular vimentin is an attachment factor that facilitates SARS-CoV-2 entry into human endothelial cells
    Razie Amraei, Chaoshuang Xia, Judith Olejnik, Mitchell R. White, Marc Arthur Napoleon, Saran Lotfollahzadeh, Blake Marie Hauser, Aaron G. Schmidt, Vipul Chimanlal Chitalia, Elke Mühlberger et al. · 2022 · Proceedings of the National Academy of Sciences
44. Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse
    Frauke Seehusen, Jordan J. Clark, Parul Sharma, Eleanor G. Bentley, Adam Kirby, Krishanthi S. Subramaniam, Sabina Wunderlin-Giuliani, Grant L. Hughes, Edward I. Patterson, Benedict Daniel Michael et al. · 2022 · Viruses
45. Macrophages on the margin: choroid plexus immune responses
    Jin Cui, Huixin Xu, Maria K. Lehtinen · 2021 · Trends in Neurosciences
46. SARS‐CoV‐2 and the brain: A review of the current knowledge on neuropathology in COVID‐19
    Aniello Maiese, Alice Chiara Manetti, Chiara Bosetti, Fabio Del Duca, Raffaele La Russa, Paola Frati, Marco Di Paolo, Emanuela Turillazzi, Vittorio Fineschi · 2021 · Brain Pathology
47. A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells
    Elena Garreta, Patricia Prado, Megan Lynn Stanifer, Vanessa Monteil, Andrés Marco, Asier Ullate‐Agote, Daniel Moya‐Rull, Amaia Vilas‐Zornoza, Carolina Tarantino, Juan P. Romero et al. · 2022 · Cell Metabolism
48. Long-COVID cognitive impairments and reproductive hormone deficits in men may stem from GnRH neuronal death
    Florent Sauvé, Sreekala S. Nampoothiri, Sophie A. Clarke, Daniela Fernandois, Caio Fernando Ferreira Coêlho, Julie Dewisme, Edouard Mills, Gaëtan Ternier, Ludovica Cotellessa, Cristina Iglesias et al. · 2023 · EBioMedicine
49. A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses
    Joep Beumer, Maarten H. Geurts, Mart Matthias Lamers, Jens Puschhof, Jingshu Zhang, Jelte van der Vaart, Anna Z. Mykytyn, Tim I. Breugem, Samra Riesebosch, Debby Schipper et al. · 2021 · Nature Communications
50. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
    Burks, Susan M., Rosas-Hernandez, Hector, Alejandro Ramirez-Lee, Manuel, Cuevas, Elvis, Talpos, John C. · 2021 · Brain Behavior and Immunity
51. Animal models for COVID-19: advances, gaps and perspectives
    Changfa Fan, Yong Wu, Rui Xiong, Yuansong Yang, Chen Ling, Susu Liu, Shunan Liu, Youchun Wang · 2022 · Signal Transduction and Targeted Therapy
52. SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
    Xiaonan Liu, Sini Huuskonen, Tuomo Laitinen, Taras A. Redchuk, Mariia S. Bogacheva, Kari Salokas, Ina Pöhner, Tiina Öhman, Arun Kumar Tonduru, Antti Hassinen et al. · 2021 · Molecular Systems Biology
53. SARS-CoV-2 Infection Induces Ferroptosis of Sinoatrial Node Pacemaker Cells
    Yuling Han, Jiajun Zhu, Liuliu Yang, Benjamin E. Nilsson-Payant, Romulo Hurtado, Lauretta A. Lacko, Xiaolu Sun, Aravind R. Gade, Christina A. Higgins, Whitney J. Sisso et al. · 2022 · Circulation Research
54. Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies
    Miaomiao Zhao, Yun Zhu, Li Zhang, Gongxun Zhong, Linhua Tai, Shuo Liu, Guoliang Yin, Jing Lü, Qiong He, Ming-Jia Li et al. · 2022 · Cell Discovery
55. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection
    R. Pei, Jian-Qi Feng, Yecheng Zhang, Hao Sun, Lian Li, Xuejie Yang, Jiang-Ping He, Shuqi Xiao, Jin Xiong, Ying Lin et al. · 2020 · Protein & Cell
56. Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry
    Dingqi Zhang, Sami Hamdoun, Ruihong Chen, Lijun Yang, Chi Kio Ip, Yuan Qing Qu, Runfeng Li, Haiming Jiang, Zifeng Yang, Sookja Kim Chung et al. · 2021 · Pharmacological Research
57. Single-cell RNA analysis reveals the potential risk of organ-specific cell types vulnerable to SARS-CoV-2 infections
    Zilong Zhang, Feifei Cui, Chen Cao, Qingsuo Wang, Quan Zou · 2021 · Computers in Biology and Medicine
58. CD147-spike protein interaction in COVID-19: Get the ball rolling with a novel receptor and therapeutic target
    Tapan Behl, Ishnoor Kaur, Lotfi Aleya, Aayush Sehgal, Sukhbir Singh, Neelam Sharma, Saurabh Bhatia, Ahmed Al‐Harrasi, SIMONA GABRIELA BUNGAU · 2021 · The Science of The Total Environment
59. TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS‐CoV‐2 infection
    Renée Marije van der Sluis, Lamin B. Cham, Albert Gris‐Oliver, Kristine Raaby Gammelgaard, Jesper G Pedersen, Manja Idorn, Ulvi Ahmadov, Sabina Sánchez-Hernández, Ena Cémalovic, Stine Høvring Godsk et al. · 2022 · The EMBO Journal
60. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
    Claudio Fenizia, Silvia Galbiati, Claudia Vanetti, Riccardo Vago, Mario Clerici, Carlo Tacchetti, Tiziana Daniele · 2021 · Cells
61. Structural and non-structural proteins in SARS-CoV-2: potential aspects to COVID-19 treatment or prevention of progression of related diseases
    Sareh Kakavandi, Iman Zare, Maryam Vaezjalali, Masoud Dadashi, Maryam Azarian, Abdullatif Akbari, Marzieh Ramezani Farani, Hamidreza Zalpoor, Bahareh Hajikhani · 2023 · Cell Communication and Signaling
62. SARS-CoV-2 infection and viral fusogens cause neuronal and glial fusion that compromises neuronal activity
    Martínez-Mármol, Ramón, Giordano-Santini, Rosina, Kaulich, Eva, Cho, Ann-Na, Przybyla, Magdalena, Riyadh, Md Asrafuzzaman, Robinson, Emilija, Chew, Keng Yih, Amor, Rumelo, Meunier, Frédéric A. et al. · 2023 · Science Advances
63. Future antiviral surfaces: Lessons from COVID-19 pandemic
    Zi-Qi Sun, K. Ostrikov · 2020 · Sustainable Materials and Technologies
64. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19
    Geraldine Nouailles, Emanuel Wyler, Peter Pennitz, Dylan Postmus, Daria Vladimirova, Julia Kazmierski, Fabian Pott, Kristina Dietert, Michael Mülleder, Vadim M. Farztdinov et al. · 2021 · Nature Communications
65. Fatal Neurodissemination and SARS-CoV-2 Tropism in K18-hACE2 Mice Is Only Partially Dependent on hACE2 Expression
    Mariano Carossino, Devin Kenney, Aoife Kateri O’Connell, Paige Montanaro, Anna E. Tseng, Hans P. Gertje, Kyle A. Grosz, Maria Ericsson, Bertrand R. Huber, Susanna A. Kurnick et al. · 2022 · Viruses
66. SARS-CoV-2 requires acidic pH to infect cells
    Alex J.B. Kreutzberger, Anwesha Sanyal, Anand Saminathan, Louis-Marie Bloyet, Spencer D. Stumpf, Zhuoming Liu, Ravi Ojha, Markku T. Patjas, Ahmed Geneid, Gustavo Scanavachi et al. · 2022 · Proceedings of the National Academy of Sciences
67. Replication, pathogenicity, and transmission of SARS-CoV-2 in minks
    Lei Shuai, G. Zhong, Q. Yuan, Zhiyuan Wen, Chong Wang, Xi-Jun He, Renqiang Liu, Jin-Liang Wang, Qin-Jian Zhao, Yu-Xiu Liu et al. · 2020 · National Science Review
68. RNA G-quadruplex in TMPRSS2 reduces SARS-CoV-2 infection
    Geng Liu, Wenya Du, Xiongbo Sang, Qiyu Tong, Ye Wang, Guoqing Chen, Yi Yuan, Lili Jiang, Wei Cheng, Dan Liu et al. · 2022 · Nature Communications
69. SARS-CoV-2 and the Host Cell: A Tale of Interactions
    Massimo Pizzato, Chiara Baraldi, Giulia Boscato Sopetto, Davide Finozzi, Carmelo Gentile, Michele Domenico Gentile, Roberta Marconi, Dalila Paladino, Alberto Raoss, Ilary Riedmiller et al. · 2022 · Frontiers in Virology
70. The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies
    Anastassios C. Papageorgiou, Imran Mohsin · 2020 · Cells
71. Endothelial Cells in Emerging Viral Infections
    Johanna Hol Fosse, Guttorm Haraldsen, Knut Falk, Reidunn Jetne Edelmann · 2021 · Frontiers in Cardiovascular Medicine
72. Role of host factors in SARS-CoV-2 entry
    John Parker Evans, Shan‐Lu Liu · 2021 · Journal of Biological Chemistry
73. Cardiac inflammation in COVID-19: Lessons from heart failure
    Sathya Dev Unudurthi, Priya Luthra, Rajendran JC Bose, Jason R. McCarthy, Maria Irene Kontaridis · 2020 · Life Sciences
74. Not only ACE2—the quest for additional host cell mediators of SARS-CoV-2 infection: Neuropilin-1 (NRP1) as a novel SARS-CoV-2 host cell entry mediator implicated in COVID-19
    Ioannis Kyrou, Harpal Singh Randeva, Demetrios A. Spandidos, Emmanouíl Karteris · 2021 · Signal Transduction and Targeted Therapy
75. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies
    Hamidreza Zalpoor, Abdullatif Akbari, Azam Samei, Razieh Forghaniesfidvajani, Monireh Kamali, Azadeh Afzalnia, Shirin Manshouri, Fatemeh Heidari, Majid Pornour, Majid Khoshmirsafa et al. · 2022 · Cellular & Molecular Biology Letters
76. SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Platelet Aggregation
    Luca Perico, Marina Morigi, Miriam Galbusera, Anna Pezzotta, Sara Gastoldi, Barbara Imberti, Annalisa Perna, Piero Luigi Ruggenenti, Roberta Donadelli, Ariela Benigni et al. · 2022 · Frontiers in Immunology
77. Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants
    Lianghui Zhang, Soumajit Dutta, Shiqin Xiong, Matthew C. Chan, Kui K. Chan, Timothy M. Fan, Keith L. Bailey, Matthew O. Lindeblad, Laura M. Cooper, Lijun Rong et al. · 2022 · Nature Chemical Biology
78. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters
    Valentin Sencio, Arnaud Machelart, Cyril Robil, Nicolas Benech, Eik Hoffmann, Chloé Galbert, Lucie Deryuter, Séverine Heumel, Aline Hantute-Ghesquier, Anne Flourens et al. · 2021 · Gut Microbes
79. Hypertension, a Moving Target in COVID-19
    Carmine Savoia, Massimo Volpe, Reinhold Hugo Kreutz · 2021 · Circulation Research
80. Excessive Matrix Metalloproteinase-1 and Hyperactivation of Endothelial Cells Occurred in COVID-19 Patients and Were Associated With the Severity of COVID-19
    Fahim Syed, Wei Li, Ryan F. Relich, Patrick M. Russell, Shanxiang Zhang, Michelle K. Zimmerman, Qigui Yu · 2021 · The Journal of Infectious Diseases
81. Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection
    Zaigham Abbas Rizvi, Rajdeep Dalal, Srikanth Sadhu, Akshay Binayke, Jyotsna Dandotiya, Yashwant Kumar, Tripti Shrivastava, Sonu Kumar Gupta, Suruchi Aggarwal, Manas Ranjan Tripathy et al. · 2022 · eLife
82. SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies
    Ceri Alan Fielding, Pragati Sabberwal, James C. Williamson, Edward J. D. Greenwood, Thomas W. M. Crozier, Wioleta Milena Zelek, Jeffrey Seow, Carl Graham, Isabella Huettner, Jonathan D. Edgeworth et al. · 2022 · eLife
83. Mucociliary Respiratory Epithelium Integrity in Molecular Defense and Susceptibility to Pulmonary Viral Infections
    Adivitiya, Manish Singh Kaushik, Soura Chakraborty, Shobi Veleri, Suneel Kateriya · 2021 · Biology
84. ACE2-Independent Alternative Receptors for SARS-CoV-2
    Suhyeon Lim, Monica Zhang, Theresa Li-Yun Chang · 2022 · Viruses
85. MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19
    Christine Hum, Julia Loiselle, Nadine Ahmed, Tyler A. Shaw, Caroline Toudic, John Paul Pezacki · 2021 · Drugs
86. The furin cleavage site of SARS-CoV-2 spike protein is a key determinant for transmission due to enhanced replication in airway cells
    Thomas P. Peacock, Daniel H. Goldhill, Jie Zhou, Laury Baillon, Rebecca Frise, Olivia C. Swann, Ruthiran Kugathasan, Rebecca Penn, Jonathan C. Brown, Raul Y. Sanchez-David et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
87. Infection Mechanism of SARS-COV-2 and Its Implication on the Nervous System
    Edwin Estefan Reza-Zaldívar, Mercedes Azucena Hernández-Sapiéns, Benito D. Minjarez, Ulises Gómez‐Pinedo, Ana Laura Márquez-Aguirre, Juan Carlos Mateos‐Díaz, Jorge Matías‐Guiu, Alejandro Arturo Canales-Aguirre · 2021 · Frontiers in Immunology
88. An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
    Omkar Indari, Shweta Jakhmola, Elangovan Manivannan, Hem Chandra Jha · 2021 · Frontiers in Pharmacology
89. Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update
    Uttpal Anand, Shweta Jakhmola, Omkar Indari, Hem Chandra Jha, Zhe‐Sheng Chen, Vijay Shankar Tripathi, José Manuel Pérez de la Lastra · 2021 · Frontiers in Immunology
90. Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection
    Martina Severa, Roberta A. Diotti, Marilena Paola Etna, Fabiana Rizzo, Stefano Fiore, Daniela Ricci, Marco Iannetta, Alessandro Sinigaglia, Alessandra Lodi, Nicasio Mancini et al. · 2021 · PLoS Pathogens
91. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS‐CoV‐2 infection
    Jia‐Mei Liu, Bai‐Hong Tan, Shuang Wu, Yue Gui, Jia‐Le Suo, Yanchao Li · 2020 · Journal of Medical Virology
92. Biological and Clinical Consequences of Integrin Binding via a Rogue RGD Motif in the SARS CoV-2 Spike Protein
    Lee Makowski, William Olson-Sidford, John W. Weisel · 2021 · Viruses
93. Neurological Complications of COVID-19: Underlying Mechanisms and Management
    Ghaydaa Ahmed Shehata, Kevin C. Lord, Michaela C. Grudzinski, Mohamed Elsayed, Ramy Abdelnaby, Hatem A. Elshabrawy · 2021 · International Journal of Molecular Sciences
94. Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication
    Santseharay Ramírez, Carlota Fernandez-Antunez, Andrea Galli, Alexander P. Underwood, Long V. Pham, Line Abildgaard Ryberg, Shan Feng, Martin Schou Pedersen, Lotte S. Mikkelsen, Sandrine Belouzard et al. · 2021 · Antimicrobial Agents and Chemotherapy
95. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin
    Lynda J. Partridge, Lucy Urwin, Martin J.H. Nicklin, David C. James, Luke R. Green, Peter N. Monk · 2021 · Cells
96. Liver disease and COVID-19: from Pathogenesis to Clinical Care
    Antonio Saviano, Florian Wrensch, M. Ghany, T. Baumert · 2020 · Hepatology
97. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective
    Sarah Halawa, Soni Savai Pullamsetti, Charles R. M. Bangham, Kurt R. Stenmark, Peter Dorfmüller, Maria G. Frid, GHAZWAN S. BUTROUS, Nicholas W. Morrell, Vinicio de Jesús Pérez, David Ian Stuart et al. · 2021 · Nature Reviews Cardiology
98. Neuropilin-1 mediates lung tissue-specific control of ILC2 function in type 2 immunity
    Jingjing Zhang, Jinxin Qiu, Wenyong Zhou, Jianping Cao, Xuefei Hu, Wenli Mi, Bing Su, Bin He, Ju Qiu, Lei Shen · 2022 · Nature Immunology
99. Heparan Sulfate Proteoglycans in Viral Infection and Treatment: A Special Focus on SARS-CoV-2
    Valeria De Pasquale, Miriam Shasa Quiccione, Simona Tafuri, Luigi Avallone, Luigi Michele Pavone · 2021 · International Journal of Molecular Sciences
100. Diabetes and COVID-19; A Bidirectional Interplay
     Paraskevi Kazakou, Vaia Lambadiari, Ignatios Ikonomidis, Aikaterini Kountouri, Georgios N. Panagopoulos, Stavros Athanasopoulos, Eleni Korompoki, Ioannis Kalomenidis, Meletios Athanasios Dimopoulos, Asimina Mitrakou · 2022 · Frontiers in Endocrinology